Stephen Hoge Moderna, Inc. (MRNA) insider trading activity

MRNA Quotes by TradingView

Stephen Hoge is President of Moderna, Inc.. Currently has a direct ownership of 1.44 Million shares of MRNA, which is worth approximately $56.9 Million. The most recent transaction as insider was on Mar 14, 2022, when has been sold 20,000 shares (Common Stock) at a price of $140.26 per share, resulting in proceeds of $2,805,200. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.44M
0.06% 3M change
4.76% 12M change
Total Value Held $56.9 Million

Stephen Hoge Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 14 2022
SELL
Open market or private sale
$2,805,200 $140.26 p/Share
20,000 Reduced 1.23%
1,610,791 Common Stock
Mar 14 2022
BUY
Exercise of conversion of derivative security
$152,000 $7.6 p/Share
20,000 Added 1.21%
1,630,791 Common Stock
Mar 03 2022
SELL
Open market or private sale
$1,479,000 $147.9 p/Share
10,000 Reduced 0.62%
1,610,791 Common Stock
Mar 03 2022
BUY
Exercise of conversion of derivative security
$9,900 $0.99 p/Share
10,000 Added 0.61%
1,620,791 Common Stock
Mar 02 2022
SELL
Open market or private sale
$1,494,400 $149.44 p/Share
10,000 Reduced 0.62%
1,610,791 Common Stock
Mar 02 2022
BUY
Exercise of conversion of derivative security
$9,900 $0.99 p/Share
10,000 Added 0.61%
1,620,791 Common Stock
Feb 24 2022
SELL
Open market or private sale
$699,000 $139.8 p/Share
5,000 Reduced 0.31%
1,610,791 Common Stock
Feb 24 2022
BUY
Exercise of conversion of derivative security
$54,500 $10.9 p/Share
5,000 Added 0.31%
1,615,791 Common Stock
Feb 23 2022
SELL
Open market or private sale
$2,094,600 $139.64 p/Share
15,000 Reduced 0.92%
1,610,791 Common Stock
Feb 23 2022
BUY
Exercise of conversion of derivative security
$89,250 $5.95 p/Share
15,000 Added 0.91%
1,625,791 Common Stock
Feb 14 2022
SELL
Open market or private sale
$3,154,200 $157.71 p/Share
20,000 Reduced 1.23%
1,610,791 Common Stock
Feb 14 2022
BUY
Exercise of conversion of derivative security
$152,000 $7.6 p/Share
20,000 Added 1.21%
1,630,791 Common Stock
Feb 10 2022
SELL
Open market or private sale
$142,048 $158.89 p/Share
894 Reduced 0.06%
1,610,791 Common Stock
Feb 09 2022
BUY
Exercise of conversion of derivative security
-
2,088 Added 0.13%
1,611,685 Common Stock
Feb 03 2022
SELL
Open market or private sale
$1,650,000 $165.0 p/Share
10,000 Reduced 0.62%
1,609,597 Common Stock
Feb 03 2022
BUY
Exercise of conversion of derivative security
$9,900 $0.99 p/Share
10,000 Added 0.61%
1,619,597 Common Stock
Feb 02 2022
SELL
Open market or private sale
$1,708,900 $170.89 p/Share
10,000 Reduced 0.62%
1,609,597 Common Stock
Feb 02 2022
BUY
Exercise of conversion of derivative security
$9,900 $0.99 p/Share
10,000 Added 0.61%
1,619,597 Common Stock
Jan 24 2022
SELL
Open market or private sale
$2,976,200 $148.81 p/Share
20,000 Reduced 1.23%
1,609,597 Common Stock
Jan 24 2022
BUY
Exercise of conversion of derivative security
$152,000 $7.6 p/Share
20,000 Added 1.21%
1,629,597 Common Stock
Jan 13 2022
SELL
Open market or private sale
$3,293,400 $219.56 p/Share
15,000 Reduced 0.92%
1,609,597 Common Stock
Jan 13 2022
BUY
Exercise of conversion of derivative security
$89,250 $5.95 p/Share
15,000 Added 0.91%
1,624,597 Common Stock
Jan 12 2022
SELL
Open market or private sale
$1,100,050 $220.01 p/Share
5,000 Reduced 0.31%
1,609,597 Common Stock
Jan 12 2022
BUY
Exercise of conversion of derivative security
$54,500 $10.9 p/Share
5,000 Added 0.31%
1,614,597 Common Stock
Jan 03 2022
SELL
Open market or private sale
$4,941,600 $247.08 p/Share
20,000 Reduced 1.23%
1,609,597 Common Stock

Also insider at

AXLA
Axcella Health Inc. Healthcare
Director
Stephen Hoge

Stephen Hoge

President
Cambridge, MA

Track Institutional and Insider Activities on MRNA

Follow Moderna, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRNA shares.

Notify only if

Insider Trading

Get notified when an Moderna, Inc. insider buys or sells MRNA shares.

Notify only if

News

Receive news related to Moderna, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on MRNA